FY19 showed solid gains in all segments, up +4.1% YoY, as antimicrobial devices take the lead
The prevention of Hospital-Acquired Infections (HAIs) continues to drive measures and practices to reduce Central Line-Associated Bloodstream Infections (CLABSIs) and is creating demand for products that can address these issues. Numerous programs and educational tools are being developed to provide measures and strategies that assist healthcare providers in the prevention and reduction of infection in acute care and other settings.
According to BioMedGPS' SmartTRAK Financial Dashboard, the Q419 US VA Adjunct Products market saw a solid increase of +3.7% for the four segments: Dressings, Antimicrobial Devices, Antimicrobial IV Skin Preps and Mechanical Securement Devices.
Among the many topics including news, financial data, charts and company revenues, covered in the comprehensive Q419/FY19 Infection Prevention: Vascular Access Adjunct Products Market Recap*, are:
- Dressings: Securement and Stabilization of VA Devices
- Antimicrobial Devices
- Antimicrobial IV Skin Preps
- Mechanical Securement Devices
- Infection Prevention Patents Issued in Q419
In Q419, Antimicrobial devices used for the securement of catheters comprised 30.6% of the VA Adjunct Products market, followed closely by the Dressings segment with 30.2% share. Revenue for Q419 IV Prep skin antisepsis products reached $
*, representing 24.4% share of the market; and Mechanical Devices used for catheter securement rounded out the market with 14.8% share and revenue of $*.
Read the complete, comprehensive Q419/FY19 Infection Prevention: Vascular Access Adjunct Products Market Recap including news, financial data, charts, company revenues and shares, plus insightful analysis from our team of experts*...
*The entire unedited article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.
